Association between angiotensin converting enzyme gene polymorphism and coronary artery disease in individuals of the South-Eastern Anatolian population

Anadolu Kardiyoloji Dergisi

Volumn 4, Issue 1, 2004, Pages 45-51

  Nacak, Muradiye ^a   Davutoǧlu, Vedat ^a,d   Soydinç, Serdar ^d   Dinçkal, Hakan ^d   Türkmen, Serdar ^a   Erbaǧci, Binnur ^b   Akçay, Murat ^d   Aynacioǧlu, Şükrü ^c  

^a Department of Cardiology ^*  (Turkey)

^b Adiyaman Devlet Hastanesi   (Turkey)

^c Epidauros Biotechnologie AG   (Germany)

^d GAZIANTEP UNIVERSITY   (Turkey)

Author keywords

ACE gene polymorphism; Coronary artery disease; South Eastern Anatolia

Indexed keywords

AGAROSE; DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; AGED; ALLELE; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GENE AMPLIFICATION; GENE DELETION; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MARKER GENE; POLYMERASE CHAIN REACTION; POPULATION RESEARCH; RISK ASSESSMENT; TURKEY (REPUBLIC);

ADULT; AGED; CASE-CONTROL STUDIES; CORONARY ANGIOGRAPHY; CORONARY ARTERIOSCLEROSIS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; MALE; MIDDLE AGED; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; TURKEY;

EID: 1842472249     PISSN: 13028723     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Mattei MG, Hubert C, Alhenc-Gelas F, Roeckel N, Corvol P, Soubrier F. Angiotensin I-converting enzyme gene is on chromosome 17. Cytogenet Cell Genet 1989; 51: 1041.
2. Fogarty DG, Maxwell AP, Doherty CC, Hughes AE, Nevine NC. ACE gene typing. Lancet 1994; 343: 851.
3. Cambien F, Poirier O, Lecerf L, et al. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 1992; 359: 641-4.
4. Tiret L, Rigat B, Visvikis S, et al. Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet 1992; 51: 197-205.
5. Brown NJ, Vaughan DE. Angiotensin converting enzyme inhibitors. Circulation 1998; 97: 1411-20.
6. Kupari M, Perola M, Koskinen P, Virolainen J, Karhunen PJ. Left ventricular size, mass, and function in relation to angiotensin-converting enzyme gene polymorphism in humans. Am J Physiol. 1994; 267: 1107-11.
7. Campbell-Boswell M, Robertson AL. Effects of angiotensin II and vasopressin on human smooth muscle cells in vitro. Exp Mol Pathol. 1981; 35: 265-76.
8. Butler R, Morris AD, Struthers AD. Angiotensin-converting enzyme gene polymorphism and cardiovascular disease. Clin Sci 1997; 93: 391-400.
9. Lindpainter K, Pfeffer MA, Kreutz R, et al. A prospective evaluation of angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease. N Engl J Med 1995; 332: 706-11.
10. Barley J, Blackwood A, Carter ND, et al. Angiotensin converting enzyme insertion/deletion polymorphism: Association with ethnic origin. J Hypertens. 1994; 12: 955-7.
11. Akar N, Aras O, Omurlu K, Cin S. Deletion polymorphism at the angiotensin converting enzyme gene in Turkish patients with coronary artery disease. Scand J Clin Lab Invest 1998; 58: 491-5.
12. Isbir T, Yilmaz H, Agachan B, Aydin M, Isbir CS. Association between angiotensin converting enzyme gene polymorphism and coronary artery disease. IUBMB Life 1999; 48: 205-7.
13. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extraction DNA from human nucleated cells. Nucleic Acids Res 1988; 16: 1215.
14. Rigat B, Hubert C, Corvol P, Soubrier F. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase1). Nucleic Acids Res 1992; 20: 1433.
15. Bohn M, Berge KE, Bakken A, Erikssen J, Berg K. Insertion/deletion (I/D) polymorphism at the locus for angiotensin I-converting enzyme and parental history of myocardial infarction. Clin Genet 1993; 44: 292-301.
16. Ludwig E, Comeli PS, Anderson JL, Marshall HW, Lalouel JM, Ward RH. Angiotensin-converting enzyme gene polymorphism is associated with myocardial infarction but not with development of coronary stenosis. Circulation 1995; 91: 2120-4.
17. Schuster H, Wienker TF, Stremler U, Noll B, Steinmetz A, Luft FC. An angiotensin-converting enzyme gene variant is associated with acute myocardial infarction. Am J Cardiol 1995; 76: 601-3.
18. Marenberg ME, Risch N, Berkman LF, Floderus B, de Faire U. Genetic susceptibility to death from coronary heart disease in a study of twins. N Engl J Med 1994; 330: 1041-6.
19. Samani NJ, Thompson JR, O'Toole L, Channer K, Woods KL. A meta analysis of the association of the deletion allele of the angiotensin-converting enzyme gene with myocardial infarction. Circulation 1996; 94: 708-12.
20. Marian AJ, Yu QT, Workman R, Roberts R. Angiotensin-converting enzyme polymorphism in hypertrophic cardiomyopathy and sudden cardiac death. Lancet. 1993; 342: 1085-6.
21. Iwai N, Ohmichi N, Nakamura Y, Kinoshita M. DD genotype of the angiotensin-converting enzyme gene is a risk factor for left ventricular hypertrophy. Circulation. 1994; 90: 2622-8.
22. Harrap SP, Davidson HR, Connor JM, et al. The angiotensin I-converting enzyme gene and predisposition to high blood pressure. Hypertension 1993; 21: 455-60
23. Winkelmann BR, Nauck M, Klein B, et al. Deletion polymorphism of the angiotensin I-converting enzyme gene is associated with increased plasma angiotensin-converting enzyme activity but not with increased risk for myocardial infarction and coronary artery disease. Ann Intern Med 1996; 12: 519-25.
24. Friedl W, Krempler F, Paulweber B, Pichler M, Sandhofer F. A deletion polymorphism in angiotensin converting enzyme gene is not associated with coronary artery disease in an Austrian population. Atherosclerosis 1995; 112: 137-43.
25. O'Donnell CJ, Lindpaintner K, Larson MG et al. Evidence for association and genetic linkage of the angiotensin-converting enzyme locus with hypertension and blood pressure in men but not women in the Framingham Heart Study. Circulation 1998; 97:1766-72.
26. McKenzie CA, Abecasis GR, Keavney B, et al. Trans-ethnic fine mapping of a quantitative trait locus for circulating angiotensin I -converting enzyme (ACE). Hum Mol Genet 2001; 10: 1077-84.
27. Zhu X, McKenzie CA, Forrester T, et al. Localization of a small genomic region associated with elevated ACE. Am J Hum Genet 2000; 67: 1144-53.
28. Naftilan AJ, Pratt RE, Dzau VJ. Induction of platelet-derived growth factor A-chain and c-myc gene expressions by angiotensin II in cultured rat vascular smooth muscle cells. J Clin Invest 1989; 83: 1419-24.
29. Schuh JR, Belhm DJ, Frierdich GE, McMahon EG, Blaine EH. Differential effects of renin-angiotensin system blockade on atherogenesis in colesterol-fed rabbits. J Clin Invest 1993; 91: 1453-8.
30. Itoh K, Yoshido S, Fukuda M. The ACE inhibitor alacepril suppresses atherogenesis independent of serum lipids in cholesterol-fed rabbits-critical analysis with new ultrasound technique. Jpn Circ J 1994; 58: 844-54.
31. Becker RH, Wiemer G, Linz W. Preservation of endothelial function by ramipril in rabbits on a long-term atherogenic diet. J Cardiovasc Pharmacol 1991; 18: S110-5.
32. Agerholm-Larsen B, Nordestgaard BG, Steffensen R, Sorensen TIA. The Copenhagen City Heart Study Group. The angiotensin-converting enzyme gene polymorphism fails to predict coronary heart disease in a case-control study of 7300 individuals (abstract). Circulation 1995; (Suppl. I): 800.
33. Eichner JE, Christiansen VJ, Moore WE, Dunn ST, Schechter F. Angiotensin-converting enzyme gene polymorphism in a cohort of coronary angiography patients. Atherosclerosis 2001; 154: 673-9.
34. Danser AH, Schalekamp MA, Box WA, et al. Angiotensin-converting enzyme in the human heart. Effect of the deletion/insertion polymorphism. Circulation 1995; 15: 1387-8.
35. Rose G. The Strategy of Preventive Medicine. New York: Oxford University Pres; 1992: P.138.
36. Rieder MJ, Taylor SL, Clark AG, Nickerson DA. Sequence variation in the human angiotensin converting enzyme. Nat Genet 1999;22:59-62.
37. Soubrier F, Martin S, Alonso A et al. High-resolution genetic mapping of the ACE-linked QTL influencing circulating ACE activity. Eur J Hum Genet 2002; 10: 553-61.
38. Villard E, Tiret L, Visvikis S, Rakotovao R, Cambien F, Soubrier F. Identification of new polymorphisms of the angiotensin I-converting enzyme (ACE) gene, and study of their relationship to plasma ACE levels by two-QTL segregation-linkage analysis. Am J Hum Genet 1996; 58: 1268-78.
39. Wang JG, Staessen JA, Tizzoni L, et al. Renal function in relation to three candidate genes. Am J Kidney Dis 2001; 38: 1158-68.
40. Iwai N, Tamaki S, Ohmichi N, Kinoshita M. The II genotype of the angiotensin-converting enzyme gene delays the onset of acute coronary syndromes. Arterioscler Thromb Vasc Biol 1997; 17: 1730-3.